New diabetes clinical trial: SGLT2i, Hepatic Glucose Production, and SNS

Published on: July 07, 2025 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: Empagliflozin 25 MG
Sponsors: The University of Texas Health Science Center at San Antonio; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting
https://ift.tt/l2mKHyz